Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of April 16, 2025, Faes Farma (FAE.MC) has a market cap of $1.34 billion USD. According to our data, Faes Farma is ranked No.4595 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Apr 16, 2025 | $1.34 B |
10.63%
|
| Dec 31, 2024 | $1.21 B |
15.22%
|
| Dec 29, 2023 | $1.05 B |
-1.80%
|
| Dec 30, 2022 | $1.07 B |
1.82%
|
| Dec 30, 2021 | $1.05 B |
5.89%
|
| Dec 31, 2020 | $0.99 B |
-26.56%
|
| Dec 31, 2019 | $1.35 B |
73.90%
|
| Dec 31, 2018 | $0.78 B |
4.75%
|
| Dec 29, 2017 | $0.74 B |
-8.97%
|
| Dec 30, 2016 | $0.81 B |
25.80%
|
| Dec 31, 2015 | $0.65 B |
66.45%
|
| Dec 31, 2014 | $0.39 B |
-31.70%
|
| Dec 31, 2013 | $0.57 B |
70.62%
|
| Dec 31, 2012 | $0.33 B |
37.10%
|
| Dec 30, 2011 | $0.24 B |
-53.27%
|
| Dec 30, 2010 | $0.52 B |
-21.36%
|
| Dec 30, 2009 | $0.66 B |
21.83%
|
| Dec 30, 2008 | $0.54 B |
-66.27%
|
| Dec 28, 2007 | $1.61 B |
-32.43%
|
| Dec 29, 2006 | $2.39 B |
68.93%
|
| Dec 30, 2005 | $1.41 B |
20.18%
|
| Dec 31, 2004 | $1.18 B |
8.12%
|
| Dec 31, 2003 | $1.09 B |
24.50%
|
| Dec 31, 2002 | $0.87 B |
-13.07%
|
| Dec 31, 2001 | $1.00 B |
219.94%
|
| Dec 29, 2000 | $0.31 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 Grifols
GRFS
|
$5.71 B |
3.909 B
|
Spain
|
 PulteGroup
PHM
|
$19.11 B |
-0.000 M
|
USA
|
 Raymond James
RJF
|
$27.91 B |
0.001 M
|
USA
|
 Bio-Rad Laboratories
BIO
|
$6.82 B |
1.204 B
|
USA
|
 Sanofi
SNY
|
$123.58 B |
-0.002 M
|
France
|
 GlaxoSmithKline
GSK
|
$72.33 B |
-0.002 M
|
UK
|
 Novartis
NVS
|
$217.12 B |
0.003 M
|
Switzerland
|
 Pfizer
PFE
|
$127.27 B |
-0.003 M
|
USA
|
| Market Cap | = | FAE.MC Stock Price | * | FAE.MC Shares Outstanding |
| = | $4.30 | * | 0.31 B | |
| = | $1.34 B |